Scientists Discover a Molecule That May Well Help the Obese Lose Weight
Posted on: Thursday, 18 August 2005, 06:00 CDT
NEW YORK, Aug. 18 /PRNewswire/ -- Increasing the levels of the molecule Oleoyl estrone (OE) in people who are very overweight may result in significant weight loss according to experts at biotechnology company Manhattan Pharmaceuticals.
Scientists hope that OE a naturally occurring molecule within our own bodies may hold the key to weight loss. At a time when statistics show an increase in obese individuals at a level of 74% since 1991, it is becoming increasingly important to find a treatment for obesity.
Researchers in Barcelona have discovered that the levels of the signaling molecule, OE, coincide with the levels of stored body fat but that this correlation breaks down in morbidly obese individuals.
"The research done evaluating OE levels in the morbidly obese indicates that the majority of patients have lower OE levels than expected for their body mass," said Bina Tejura, the Assistant Chief Medical Officer for Manhattan Pharmaceuticals. "This leads to the possibility that raising OE levels in the obese will suppress appetite and cause weight loss."
Scientists have shown OE regulates appetite and gives the feeling of satiety in animal studies, causing an average weight loss of 12-20% of total weight in pre-clinical trials.
Ongoing clinical trials may show OE as a viable new treatment that is more effective and have fewer side effects than current options, including gastric bypass surgery or drugs on the market today.
Manhattan Pharmaceuticals
CONTACT: Lynn Granito of Investor Relations Group,lgranito@investorrelationsgroup.com, +1-212-825-3210, for ManhattanPharmaceuticals
Source: PRNewswire
Related Articles
- Two L A Weight Loss Clients Lose Their Way to New Year Stardom
- Sixty Percent of Consumers Researching Weight Loss Use the Internet, Seeking Information on Weight Loss Programs, Diets and Medications
- Manhattan Pharmaceuticals Receives SwissMedic's Approval to Commence Phase IIa Trial With OE, Its Oral Obesity Drug Candidate
- Weight Loss Lowers Hormone Levels in Obese Kids
- Manhattan Pharmaceuticals Presents Preliminary Phase I Results of Experimental Obesity Drug
- Manhattan Pharmaceuticals to Present Preliminary Phase I Obesity Drug Data at 2005 Annual Meeting of NAASO
- Positive Data for Manhattan Pharmaceuticals' Oleoyl Estrone Presented at the 14th European Congress on Obesity
- Study Provides New Information on Efficacy of Manhattan Pharmaceuticals' Obesity Treatment Candidate
- Manhattan Pharmaceuticals Begins Patient Dosing in First Phase I Clinical Trial for Oleoyl Estrone
- New Weight-Loss Device to Be Tested
 |
 |
User Comments (0)
RSS Feeds